Industry News
Group to assess platform tech needs
A government committee set up to assess Victoria's platform technology needs is expected to report its findings by mid-year. [ + ]
Epilepsy breakthrough for Adelaide researchers
A surprise finding by a team of Adelaide scientists has provided the first evidence that the same gene on the X-chromosome may be responsible for some forms of both epilepsy and intellectual disability. [ + ]
Queensland's modest benefactor strikes again
The golden reach of a US philanthropist has touched the Queensland Institute of Medical Research again. [ + ]
Gene tech bill goes to ACT assembly
A Bill dealing with the use of gene technologies and their products in the ACT has been tabled in the Legislative Assembly. The Gene Technology Bill 2000, was tabled by Chief Minister Jon Stanhope.
[ + ]Xenome seals deal with big European
Fresh from inking pacts with two drug development companies, marine toxin specialist Xenome Ltd is on the verge of finalising many more similar deals, says CEO Tony Evans. [ + ]
Mixed results for Vita Life Sciences
Biopharmaceutical manufacturer and distributor Vita Life Sciences (ASX:VLS) posted a full-year revenue drop today because of a reduced sales forecast in its key Asian markets. [ + ]
Popular genetics: Body Shop to stock DNA test
A British company offering personalised DNA tests for diet and lifestyle genes may begin marketing the product in Australia by the end of the year, but Australian geneticists were sceptical about its efficacy. [ + ]
Micromedical's one-day fundraising spree
Artificial heart company MicroMedical Industries raised almost $11 million in just over 24 hours through a share placement directed at new investors. [ + ]
Launched: the guide to avoiding ethical debate
A handbook to help clarify the decision-making process of research ethics committees was today launched by the Federal Health and Ageing Minister. [ + ]
Networking event for young biotech
A new group within industry association AusBiotech is about to host its first networking event. [ + ]
FDA approves Sirtex cancer treatment
Sydney company Sirtex Medical's novel liver cancer treatment has been approved by the US Food and Drug Administration (FDA), opening the door to what the company says is a billion dollar market. [ + ]
Cloning rights coup for Stem Cell Sciences
Melbourne company Stem Cell Sciences has secured the worldwide rights to use technology for therapeutic cloning developed at the Monash Institute for Reproduction and Development and the Centre for Animal Biotechnology at the University of Melbourne. [ + ]
Fenner, innovators honoured
World-renowned microbiologist Prof Frank Fenner was last night (March 7) honoured with a prestigious lifetime contribution award from the Ian Clunies Ross Memorial Foundation. [ + ]
Equity-minded researchers punished by tax laws
Harsh tax treatment of research institute scientists trying to commercialise their inventions is harming Australia's national interests, bio-industry leaders warn. [ + ]
Dear Minister: research must continue
Australian scientists and scientific organisations are lobbying the Federal government in an effort to persuade them to continue to allow stem cell research using spare IVF embryos. [ + ]